Blue Jet Healthcare has reported its financial performance for the quarter and year ended March 31, 2026. The board has recommended a final dividend of Rs. 1.2 per share (60%) for the fiscal year. Furthermore, the company has unveiled a strategic plan to raise up to Rs. 10,000 million through various capital-raising instruments, subject to shareholder approval, and announced an upcoming Extra-Ordinary General Meeting scheduled for June 17, 2026.
Fiscal Year 2025-26 Financial Highlights
For the financial year ended March 31, 2026, Blue Jet Healthcare achieved a robust financial performance. The company reported a total annual income of Rs. 10,159.75 million, with a profit for the year reaching Rs. 2,478.16 million. Earnings per share (EPS) for the fiscal year stood at Rs. 14.29.
In the fourth quarter (Jan-Mar 2026), the company recorded total income of Rs. 2,575.88 million, resulting in a quarterly profit of Rs. 643.44 million. These results reflect the company’s sustained operations in the manufacturing of artificial sweeteners, contrast media, and pharma intermediates.
Dividend Recommendation
Reflecting on the strong annual performance, the Board of Directors has recommended a final dividend of Rs. 1.2 per equity share, representing a 60% payout on the face value of Rs. 2 per share. This proposal is pending approval from the company’s members at the next Annual General Meeting.
Strategic Capital Expansion
To support future growth initiatives, the board has proposed a plan to raise funds of up to Rs. 10,000 million. This capital expansion will be pursued through the issuance of various instruments, including equity shares, convertible debentures, or other equity-linked securities. The company may utilize methods such as Qualified Institutions Placements (QIP) or preferential issues to execute this funding strategy, ensuring the company is well-positioned for future operational demands.
Governance and Upcoming Meetings
The company also announced the re-appointment of M/s. H.H. Chimthanawala & Co. as the internal auditor for the 2026-27 financial year. Additionally, shareholders are notified that an Extra-Ordinary General Meeting is scheduled for June 17, 2026, at 11:00 a.m. (IST), which will be conducted via video conferencing to address the proposed funding measures.
Source: BSE
